ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CNCR ETF Series Solutions Trust Range Cancer Therapeutics

14.9587
-0.0813 (-0.54%)
Last Updated: 13:12:19
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue
Operating Income
Pre Tax Income
Net Income
Preferred Dividends
Basic Earnings Per Share (EPS)
EBIT
EBITDA
Year End August 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 122k148k237k224k177k190k153k70k
Operating Income 00000000
Pre Tax Income 00000000
Net Income -2k-70k-177k-13.61M10.92M5.7M-17.58M-4.62M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.002-0.044-0.077-7.7787.2783.93-11.719-5.771
EBIT -2k-70k-177k-108k-118k-166k-80k-70k
EBITDA -2k-70k-177k-108k-118k-166k-80k-70k

Your Recent History

Delayed Upgrade Clock